COSMOS Pharmaceutical Corporation
3349.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥57,038 | ¥52,301 | ¥45,928 | ¥37,362 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥12,240 | ¥12,199 | ¥10,221 | ¥8,577 |
| Inventory | ¥92,323 | ¥86,173 | ¥77,479 | ¥66,363 |
| Other Curr. Assets | ¥1,164 | ¥1,092 | ¥1,028 | ¥980 |
| Total Curr. Assets | ¥165,622 | ¥154,333 | ¥137,085 | ¥115,471 |
| Property Plant & Equip (Net) | ¥331,125 | ¥295,798 | ¥274,655 | ¥239,035 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥446 | ¥497 | ¥547 | ¥433 |
| Long-Term Investments | ¥4,464 | ¥4,386 | ¥4,310 | ¥4,179 |
| Tax Assets | ¥2,913 | ¥2,893 | ¥2,268 | ¥1,966 |
| Other NC Assets | ¥20,185 | ¥18,636 | ¥2,095 | ¥1,966 |
| Total NC Assets | ¥359,133 | ¥322,210 | ¥283,875 | ¥247,579 |
| Other Assets | ¥4 | ¥3 | ¥7 | ¥2 |
| Total Assets | ¥524,755 | ¥476,546 | ¥420,967 | ¥363,052 |
| Liabilities | – | – | – | – |
| Payables | ¥177,125 | ¥179,549 | ¥161,852 | ¥139,224 |
| Short-Term Debt | ¥5,682 | ¥4,581 | ¥2,741 | ¥1,387 |
| Tax Payable | ¥0 | ¥5,572 | ¥6,275 | ¥4,995 |
| Deferred Revenue | ¥380 | ¥522 | ¥519 | ¥350 |
| Other Curr. Liab. | ¥27,177 | ¥13,017 | ¥12,894 | ¥8,426 |
| Total Curr. Liab. | ¥220,680 | ¥213,229 | ¥192,053 | ¥162,063 |
| LT Debt | ¥37,202 | ¥23,385 | ¥10,018 | ¥3,000 |
| Deferred Rev, NC | ¥0 | ¥4,166 | -¥442 | -¥451 |
| Deferred Tax Liab, NC | ¥416 | ¥432 | ¥442 | ¥451 |
| Other NC Liab. | ¥4,591 | ¥4,325 | ¥4,126 | ¥4,125 |
| Total NC Liab. | ¥46,610 | ¥31,876 | ¥17,842 | ¥10,482 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥7,073 | ¥6,097 | ¥5,442 | ¥5,026 |
| Total Liabilities | ¥267,290 | ¥245,105 | ¥209,895 | ¥172,545 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥4,178 | ¥4,178 | ¥4,178 | ¥4,178 |
| Retained Earnings | ¥248,309 | ¥222,284 | ¥202,485 | ¥181,954 |
| AOCI | ¥100 | ¥102 | ¥40 | ¥5 |
| Other Equity | ¥2 | ¥2 | ¥0 | ¥0 |
| Total Equity | ¥257,463 | ¥231,442 | ¥211,071 | ¥190,506 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥524,755 | ¥476,544 | ¥420,966 | ¥363,051 |
| Net Debt | -¥14,154 | -¥24,335 | -¥33,169 | -¥32,975 |